The Analysis Study of Low Dose Aspirin for Prevention of Superimposed Preeclampsia in Women with Chronic Hypertension: A Comprehensive Systematic Review
Keywords:
low dose aspirin, prophylactic aspirin, pregnancy, chronic hypertension, preeclampsia, superimposed preeclampsiaAbstract
Background: Chronic hypertension (cHTN) is the greatest risk factor for the development of preeclampsia. Low-dose aspirin has been used as a therapy for preeclampsia prevention. This study aims to show effectiveness of low dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. Several different online reference sources, like Pubmed and ScienceDirect, were used to do this. Results: We compiled a total of 16 papers, 9 of which came from PubMed and 7 of which came from ScienceDirect. We excluded 1 review article, 1 duplicate article, 4 articles having ineligible subject, 3 articles having ineligible intervention, and 2 articles having ineligible outcomes data. In the end, we included five research that met the criteria. Conclusion: Low dose aspirin may reduce the incidence of superimposed preeclampsia in pregnant women with cHTN. However, a further investigations is still needed to determine the effectiveness.
References
Leon MG, Moussa HN, Longo M, Pedroza C, Haidar ZA, Mendez-Figueroa H, et al. Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension. In: American Journal of Perinatology. Thieme Medical Publishers, Inc.; 2016. p. 745–50.
Kametas NA, Nzelu D, Nicolaides KH. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Vol. 226, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2022. p. S1182–95.
Banala C, Moreno S, Cruz Y, Boelig RC, Saccone G, Berghella V, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. In: American Journal of Obstetrics and Gynecology. Mosby Inc.; 2020. p. 419.e1-419.e16.
Walsh SW, Strauss JF. The road to low-dose aspirin therapy for the prevention of preeclampsia began with the placenta. Vol. 22, International Journal of Molecular Sciences. MDPI; 2021.
Lin L, Li G, Zhang W, Wang YL, Yang H. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells. J Cell Physiol. 2019 Oct 1;234(10):18928–41.
Patrono C. Aspirin. In: Platelets. Elsevier; 2019. p. 921–36.
Lin L, Huai J, Li B, Zhu Y, Juan J, Zhang M, et al. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022 Feb 1;226(2):251.e1-251.e12.
Moore GS, Allshouse AA, Post AL, Galan HL, Heyborne KD. Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: A secondary analysis of the MFMU High-Risk Aspirin Study. Journal of Perinatology. 2015 May 30;35(5):328–31.
Muldoon KA, McLean C, El-Chaár D, Corsi DJ, Rybak N, Dagvadorj A, et al. Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation. Journal of Maternal-Fetal and Neonatal Medicine. 2023;36(1).
Tolcher MC, Sangi-Haghpeykar H, Mendez-Figueroa H, Aagaard KM. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race. In: American Journal of Obstetrics and Gynecology MFM. Elsevier Inc.; 2020.
Xiang X, Wang F, Zhao N, Zhou Z. Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo. Cell Mol Biol. 2020 Dec 31;66(8):9–13.
Casagrande L, Rezende GP, Guida JP, Costa RS, Parpinelli MA, Surita FG, et al. Maternal and perinatal outcomes related to superimposed pre-eclampsia in a Brazilian cohort of women with chronic hypertension. International Journal of Gynecology and Obstetrics. 2020 May 1;149(2):148–53.
Roberts JM, King TL, Barton JR, Beck S, Bernstein IM, Buck TE, et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gynecol. 2023 Sep 1;229(3):193–213.
Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Vol. 226, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2022. p. S1108–19.
Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018 Jun 1;218(6):612.e1-612.e6.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Lora Coarnita BrGirsang, Anisa (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
